1
|
Ding J, Gu H, Yang Z, Lu Y, Guo G. Breast metastasis from lung adenocarcinoma: a case report and review of the literature. Front Oncol 2024; 14:1370453. [PMID: 38841167 PMCID: PMC11150669 DOI: 10.3389/fonc.2024.1370453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2024] [Accepted: 04/26/2024] [Indexed: 06/07/2024] Open
Abstract
Lung cancer (LC) is one of the most lethal and most prevalent malignant tumors, and lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer. Breast cancer (BC) is the most common cancer worldwide, but metastases to the breast from extramammary neoplasms are rare, especially from the lung. Early diagnosis and differentiation of primary from metastatic breast carcinoma are essential. Here, we present a case of metastases to the breast from lung adenocarcinoma, the treatment options varied according to disease progression.
Collapse
Affiliation(s)
| | | | | | | | - Guilong Guo
- Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
| |
Collapse
|
2
|
Petersbourg D. Breast Metastasis: An Unusual Cause of Malignant Breast Lesion. J Belg Soc Radiol 2024; 108:27. [PMID: 38523726 PMCID: PMC10959136 DOI: 10.5334/jbsr.3544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2024] [Accepted: 03/04/2024] [Indexed: 03/26/2024] Open
Abstract
Teaching point: Although rare, an intra-mammary metastasis from extramammary cancer should be considered in a patient with an oncological history.
Collapse
|
3
|
Chabot C, Coman CG, Borgmann FK, Crisan F, Janssens D, Azzouzi DE. Breast metastases from extra-mammary cancers: A report of 3 challenging cases and literature review. Radiol Case Rep 2024; 19:1100-1105. [PMID: 38229605 PMCID: PMC10789930 DOI: 10.1016/j.radcr.2023.12.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Revised: 12/11/2023] [Accepted: 12/12/2023] [Indexed: 01/18/2024] Open
Abstract
We report 3 cases of patients with a history of extra-mammary cancer who presented with breast nodules, leading to diagnostic challenges and occasional misleading imaging findings. These cases highlight the significance of radiologists considering breast metastases as a potential component of the differential diagnosis when assessing patients with a history of cancer who exhibit palpable breast nodules. Furthermore, these cases underscore the importance of integrating various imaging techniques with histological and immunohistochemical analyses of the lesions to achieve precise diagnoses, ultimately ensuring the highest quality of care for these patients.
Collapse
Affiliation(s)
- Caroline Chabot
- Department of Radiology and Plastic Surgery, Centre Hospitalier de Luxembourg, 4 Rue Nicolas-Ernest Barblé, 1210 Luxembourg
- Department of Radiology, Université Catholique de Louvain, Avenue Emmanuel Mounier 51, Bruxelles Woluwe, Belgium
| | - Corneliu-George Coman
- Department of Radiology and Plastic Surgery, Centre Hospitalier de Luxembourg, 4 Rue Nicolas-Ernest Barblé, 1210 Luxembourg
| | - Felix Kleine Borgmann
- Department of Cancer Research, Luxembourg Institute of Health, 6A Rue Nicolas-Ernest Barblé, 1210 Luxembourg
| | - Flaviu Crisan
- Department of Pathology, Laboratoire National de la Santé, 1 Rue Louis Rech, Dudelange, 3555, Luxembourg
| | - Daniel Janssens
- Department of Radiology and Plastic Surgery, Centre Hospitalier de Luxembourg, 4 Rue Nicolas-Ernest Barblé, 1210 Luxembourg
| | - Dounia El Azzouzi
- Department of Radiology and Plastic Surgery, Centre Hospitalier de Luxembourg, 4 Rue Nicolas-Ernest Barblé, 1210 Luxembourg
| |
Collapse
|
4
|
Sellers CM, Ortiz-Perez T, Dhamne S, Roark A, Gilman L. Intramammary Metastases from Extramammary Malignancies: An Update. CURRENT BREAST CANCER REPORTS 2023. [DOI: 10.1007/s12609-023-00484-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/30/2023]
|
5
|
Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast. Appl Immunohistochem Mol Morphol 2021; 28:661-668. [PMID: 31517642 PMCID: PMC7664953 DOI: 10.1097/pai.0000000000000808] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
The breast is a rare site for metastases, and their molecular characteristics have not been studied yet. Intrinsic molecular genetics, cancer characteristics, and breast tissue immune responses in diverse metastases to the breast have not been previously studied. We identified 64 patients with cancers metastatic to the breast: 51 carcinomas and 13 melanomas. Programmed death ligand 1 (PD-L1), steroid receptors, and HER2/neu expressions were evaluated using immunohistochemistry. Gene sequencing, copy number alterations, microsatellite instability, and tumor mutational burden were performed using next-generation sequencing platforms. The 3 most common primary sites for metastatic carcinomas were lung (37%), ovary (29%), and fallopian tubes/peritoneum (14%). TP53 mutations were commonly (50%) observed among the carcinoma cases, while other mutations were characteristic for the primary cancers (VHL in renal, BRCA1 in the fallopian tube, and BRAF in melanomas). High tumor mutational burden was detected in 5/14 carcinomas and 3/7 melanomas. Tumor cell PD-L1 expression was detected in 6 carcinomas, but not in any of the melanomas, whereas immune cells' expression of PD-L1 was seen in 17 carcinomas and 6 melanomas. Estrogen receptor status was positive in 13/49 carcinomas including 12 adenocarcinomas originating from the ovary and fallopian tube or peritoneum and 1 duodenal neuroendocrine carcinoma. No carcinoma was HER2/neu positive. Intrinsic genetic characteristics of the metastases to the breast followed the pattern commonly seen in primary tumors. Biomarkers of potential benefit to immune checkpoint inhibition therapy were limited to PD-L1-positive non-small cell lung cancer. No common characteristics of the heterogeneous group of tumor metastases to this organ were identified.
Collapse
|
6
|
Faast A, Ikeda DM, Pittman S, DeMartini W, Kozlov A. FDG Avid Abnormalities in the Breast: Breast Cancer Mimics. CURRENT RADIOLOGY REPORTS 2021. [DOI: 10.1007/s40134-021-00383-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Kozlov A, Pantel A, Iagaru A, Ikeda D. Pulmonary Adenocarcinoma Metastasis to the Breast Unexpectedly Discovered on Re-staging 18F-FDG PET/CT in a Woman With a Normal Screening Mammogram. Clin Lung Cancer 2020; 22:e438-e441. [PMID: 32680805 DOI: 10.1016/j.cllc.2020.06.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Accepted: 06/11/2020] [Indexed: 11/29/2022]
Affiliation(s)
- Andrew Kozlov
- Department of Radiology, Oregon Health and Sciences University, Portland, OR.
| | - Austin Pantel
- Department of Radiology, Nuclear Medicine Division, Hospital of the University of Pennsylvania, Philadelphia, PA
| | - Andrei Iagaru
- Department of Radiology, Nuclear Medicine and Molecular Imaging Division, Stanford University School of Medicine, Stanford, CA
| | - Debra Ikeda
- Department of Radiology, Breast Imaging Division, Stanford University School of Medicine, Stanford, CA
| |
Collapse
|
8
|
Ishikawa Y, Tabei I, Fushimi A, Fuke A, Sekine C, Okamoto T, Takeyama H. Male breast metastasis of ureteral cancer: a case report. Surg Case Rep 2020; 6:58. [PMID: 32232598 PMCID: PMC7105547 DOI: 10.1186/s40792-020-00804-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2019] [Accepted: 02/12/2020] [Indexed: 12/09/2022] Open
Abstract
Background Breast metastasis from extra-mammary primary tumors is extremely rare. We recently experienced a rare case of a male breast metastasis of ureteral cancer and will provide a case report. Case presentation A 74-year-old man developed a ureteral cancer and underwent left nephroureterectomy with lymph node dissection. Although enlarged abdominal lymph nodes did not disappear completely after chemoradiotherapy, further extensive therapy was not performed. A mass just below the nipple of his right breast was acknowledged and he visited our department. Histological diagnosis was invasive carcinoma. It was initially diagnosed as a primary breast cancer, and he underwent a mastectomy and a sentinel lymph node biopsy. There was no intraductal lesion and the border of the tumor was clear. It was very similar to that of the previous ureteral cancer. The final diagnosis was breast metastasis of ureteral cancer rather than primary breast cancer. The postoperative course was good, but multiple lung metastases appeared 2 months after surgery. He eventually died of cancerous lymphangiopathy. Conclusion It is important to accurately diagnose primary breast cancer or breast metastasis so as not to cause extra-invasion, but it was considered difficult to make a complete preoperative diagnosis.
Collapse
Affiliation(s)
- Yoshitaka Ishikawa
- Moriya Keiyu Hospital Department of Surgery, 980-1 Tatsuzawa, Moriya-shi, Ibaraki, 302-0118, Japan
| | - Isao Tabei
- The Jikei University School of Medicine Daisan Hospital Department of Surgery, 4-11-1 Izumihoncho, Komae-shi, Tokyo, 201-8601, Japan.
| | - Atsushi Fushimi
- The Jikei University School of Medicine Hospital Division of Breast Thyroid & Endocrine Surgery, 3-19-18 Nishishimbashi, Minato-ku, Tokyo, 105-8471, Japan
| | - Azusa Fuke
- The Jikei University School of Medicine Daisan Hospital Department of Surgery, 4-11-1 Izumihoncho, Komae-shi, Tokyo, 201-8601, Japan
| | - Chikako Sekine
- The Jikei University School of Medicine Hospital Division of Breast Thyroid & Endocrine Surgery, 3-19-18 Nishishimbashi, Minato-ku, Tokyo, 105-8471, Japan
| | - Tomoyoshi Okamoto
- The Jikei University School of Medicine Daisan Hospital Department of Surgery, 4-11-1 Izumihoncho, Komae-shi, Tokyo, 201-8601, Japan
| | - Hiroshi Takeyama
- The Jikei University School of Medicine Hospital Division of Breast Thyroid & Endocrine Surgery, 3-19-18 Nishishimbashi, Minato-ku, Tokyo, 105-8471, Japan
| |
Collapse
|
9
|
Mastoraki A, Schizas D, Giannakodimos I, Rebakos A, Margaris I, Katsaros I, Vagios I, Vassiliu P, Pikoulis E. Malignant melanoma of the breast: controversies in the diagnosis and therapeutic management of a rare nosologic entity. Int J Dermatol 2020; 59:1057-1064. [PMID: 32115682 DOI: 10.1111/ijd.14818] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2019] [Revised: 01/02/2020] [Accepted: 01/24/2020] [Indexed: 12/18/2022]
Abstract
Melanoma of the breast is an infrequent entity, presenting as either primary or metastatic from extramammary solid neoplasms. Depending on the involvement of the skin, primary malignant melanoma of the breast (PMMB) can be classified as cutaneous or noncutaneous. Cutaneous PMMB accounts for <5% of all melanomas and only 0.5% of all breast cancers. Furthermore, despite the rarity of metastatic breast neoplasms, melanoma comprises a frequent source of metastases. Metastatic potential of melanoma is associated with poor prognosis, and the majority of patients present more than one metastatic foci at the time of diagnosis. Diagnostic approach for both primary and metastatic melanomas of the breast is substantiated by fine needle aspiration (FNA) cytology along with immunohistochemistry. Nevertheless, verification of a metastatic mammary melanoma requires the discovery of a primary lesion. The mainstay of treatment for primary tumors is surgery, with radical local excision and axillary lymph node dissection or, on occasion, axillary sentinel node resection, while for metastatic tumors it depends on the specificities of the melanoma. Adjuvant therapy is always implemented. The aim of this survey is to meticulously review the literature of primary and metastatic malignant melanomas of the breast and report epidemiologic and clinicopathologic data for this rare entity. Clinical features, histogenesis, morphological, and immunochemical findings are discussed, while the role of current diagnostic and therapeutic management of this uncommon entity is emphasized.
Collapse
Affiliation(s)
- Aikaterini Mastoraki
- 4th Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Chaidari, Athens, Greece
| | - Dimitrios Schizas
- 1st Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece
| | - Ilias Giannakodimos
- 4th Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Chaidari, Athens, Greece
| | - Athanasios Rebakos
- 4th Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Chaidari, Athens, Greece
| | - Ioannis Margaris
- 4th Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Chaidari, Athens, Greece
| | - Ioannis Katsaros
- 1st Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece
| | - Ilias Vagios
- 1st Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece
| | - Pantelis Vassiliu
- 4th Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Chaidari, Athens, Greece
| | - Emmanouil Pikoulis
- 3rd Department of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Chaidari, Athens, Greece
| |
Collapse
|
10
|
Magnoni F, Di Tonno C, Accardo G, Calvello M, Corso G, Sacchini V, Galimberti V, Veronesi P. Breast cancer with rare metastatic manifestation. Future Oncol 2019; 15:2437-2440. [PMID: 31339064 DOI: 10.2217/fon-2019-0263] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Affiliation(s)
- Francesca Magnoni
- IEO, European Institute of Oncology, IRCCS, Division of Breast Cancer Surgery, Milan, Italy
| | - Clementina Di Tonno
- IEO, European Institute of Oncology, IRCCS, Division of Pathology, Milan, Italy
| | - Giuseppe Accardo
- IEO, European Institute of Oncology, IRCCS, Division of Breast Cancer Surgery, Milan, Italy
| | - Mariarosaria Calvello
- IEO, European Institute of Oncology, IRCCS, Division of Cancer Prevention & Genetics, Milan, Italy
| | - Giovanni Corso
- IEO, European Institute of Oncology, IRCCS, Division of Breast Cancer Surgery, Milan, Italy.,Faculty of Medicine, University of Milan, Milan, Italy
| | - Virgilio Sacchini
- IEO, European Institute of Oncology, IRCCS, Division of Breast Cancer Surgery, Milan, Italy.,Faculty of Medicine, University of Milan, Milan, Italy
| | - Viviana Galimberti
- IEO, European Institute of Oncology, IRCCS, Division of Breast Cancer Surgery, Milan, Italy
| | - Paolo Veronesi
- IEO, European Institute of Oncology, IRCCS, Division of Breast Cancer Surgery, Milan, Italy.,Faculty of Medicine, University of Milan, Milan, Italy
| |
Collapse
|
11
|
Kitahara M, Hozumi Y, Asada R, Sawa A, Saito H, Iijima T. Intramammary Metastasis in a Patient with a History of Renal Cell Carcinoma: A Case Report. Case Rep Oncol 2018; 11:318-322. [PMID: 29928210 PMCID: PMC6006650 DOI: 10.1159/000489391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Accepted: 04/18/2018] [Indexed: 11/29/2022] Open
Abstract
Intramammary metastasis of renal cell carcinoma (RCC) is extremely rare, accounting for only 1.5% of all intramammary metastases. Distinguishing intramammary metastases from benign tumors and breast cancer is clinically problematic. Some patients undergo excessive surgery after a misdiagnosis of breast cancer instead of a mammary tumor. We performed a core needle biopsy (CNB) of a breast mass that developed in a 71-year-old woman after surgeries for bilateral RCC and breast cancer, leading to a diagnosis of intramammary metastasis of RCC. In this case, the CNB and immunohistochemical examination were critical for reaching a definitive diagnosis. We conclude that, when examining patients with mammary tumors, establishing their history of malignant tumors may help diagnose intramammary metastasis and select the best treatment strategy.
Collapse
Affiliation(s)
- Miyuki Kitahara
- Department of Breast Surgery, Ibaraki Prefectural Central Hospital and Cancer Center, Kasama, Japan
| | - Yasuo Hozumi
- Department of Breast Surgery, Ibaraki Prefectural Central Hospital and Cancer Center, Kasama, Japan
| | - Rio Asada
- Department of Breast Surgery, Ibaraki Prefectural Central Hospital and Cancer Center, Kasama, Japan
| | - Aya Sawa
- Department of Breast Surgery, Ibaraki Prefectural Central Hospital and Cancer Center, Kasama, Japan
| | - Hitoaki Saito
- Department of Pathology, Ibaraki Prefectural Central Hospital and Cancer Center, Kasama, Japan
| | - Tatsuo Iijima
- Department of Pathology, Ibaraki Prefectural Central Hospital and Cancer Center, Kasama, Japan
| |
Collapse
|
12
|
Abstract
Introduction Breast metastases are very uncommon, either from solid tumors or malignant melanoma. Case report We present the case of a 42-year-old woman with a history of cutaneous melanoma of the shoulder excised 21 years ago. She presented with a palpable lump in the upper outer quadrant of the right breast. Ultrasound demonstrated a solid mass within a cystic lesion. A core biopsy was taken and first histology reported a poorly differentiated primary breast cancer suspected to be triple negative. MRI detected a satellite lesion in the same breast, a focus of suspected enhancement in the other breast, and the extramammary finding of an enhancing pulmonary lesion. Staging computed tomography detected widespread metastases to the lungs, brain, subcutaneous left shoulder, liver, pancreas, and hepatorenal recess. A core biopsy was taken from the left breast lesion and the previous slides were reviewed; histopathology and immunohistochemistry were in keeping with metastasis from melanoma. Conclusions The possibility of a metastatic lesion to the breast should be taken into account in any patient presenting with a breast lump and a previous history of melanoma. Breast involvement cannot be considered an isolated finding, as it might be the first manifestation of widespread disease.
Collapse
|
13
|
Longo R, Melgar E, Campitiello M, Plastino F, Eid N, Quirin I, Hennequin L, Grignon Y, Gunther M, Quétin P. Breast metastasis from squamous cell carcinoma of the oropharynx: a case report. J Med Case Rep 2017; 11:355. [PMID: 29268777 PMCID: PMC5740581 DOI: 10.1186/s13256-017-1500-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2017] [Accepted: 10/25/2017] [Indexed: 11/25/2022] Open
Abstract
Background Breast metastases from extramammary tumors are extremely rare, the most common primary tumors being contralateral breast carcinoma, followed by lung, gynecological, gastrointestinal, melanoma, and hematological cancers. Only a few cases deriving from head and neck squamous cell carcinoma have been reported in the literature to date. Case presentation We report a case of a 47-year-old Caucasian woman who presented to our hospital with a solitary breast lesion in the right upper external quadrant associated with multiple bone and visceral metastases. Two years before, she had undergone radical resection of a squamous cell carcinoma of the oropharynx (stage pT2, pN1), which was followed by adjuvant radiotherapy. Breast ultrasound showed a hypoechogenic tumor lesion of 4 cm in the right upper external quadrant that was associated with multiple axillary and infra-/supraclavicular adenopathies. A positron emission tomographic scan documented multiple visceral and bone metastases with a single hypermetabolic lesion of the right breast. The results of histology and immunohistochemistry were consistent with a metastasis from a squamous cell carcinoma. The patient died of acute respiratory insufficiency 1 month after her breast metastasis diagnosis and before starting any systemic antitumoral treatment. Conclusions Although breast metastases are extremely rare, they should be considered in any patient with a history of cancer and confirmed by histology and immunohistochemistry because they are very difficult to distinguish from other primary breast tumors based only on clinical and radiological features. There are no standardized treatment guidelines for breast metastasis management. Surgery and radiotherapy can play a role in symptom palliation, but they do not have any relevant impact on survival, the prognosis being poor, with an estimated overall survival less than 1 year from diagnosis.
Collapse
Affiliation(s)
- Raffaele Longo
- Division of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France.
| | - Emmanuelle Melgar
- Division of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France
| | - Marco Campitiello
- Division of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France
| | - Francesca Plastino
- Division of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France
| | - Nada Eid
- Division of Medical Oncology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France
| | - Isabelle Quirin
- Division of Radiology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France
| | - Laurent Hennequin
- Division of Radiology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France
| | - Yves Grignon
- Division of Pathology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France
| | - Michel Gunther
- Division of Gynecology, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France
| | - Philippe Quétin
- Division of Radiotherapy, Centre Hospitalier Régional (CHR) Metz-Thionville, 1 Allée du Château, 57085, Ars-Laquenexy, France
| |
Collapse
|
14
|
Markovic M, Jovanovic D, Todorovic Z, Zivkovic M, Dagovic A, Mitrović S, Petrović M, Nešić J. Primary Small Cell Carcinoma Of Lung With Metachronous Breast Metastasis. SERBIAN JOURNAL OF EXPERIMENTAL AND CLINICAL RESEARCH 2017. [DOI: 10.1515/sjecr-2016-0087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Breast metastases from an extra-mammary malignancy are rare. Among the lung malignancies that metastasise in the breasts, previous literature has described approximately 30 cases of NSCLC and only a few cases of SCLC. Here, we present a 54-year-old woman with metachronous breast metastasis from pulmonary small cell carcinoma. She presented with a soft tissue mass in the right lung hilum. After bronchoscopy with biopsy, SCLC was verified. Th e patient was given 4 cycles of etoposide and cisplatin followed by radiation therapy. Seven months after the diagnosis of primary lung cancer, the patient palpated a mass in her right breast. Clinical examination and further diagnostics revealed the suspected malignancy, and a radical mastectomy was performed. Immunohistochemical findings suggested metastatic SCLC in the breast. Differentiation between primary and metastatic cancer in the breast is very important for therapeutic planning
Collapse
Affiliation(s)
- Marina Markovic
- University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Internal medicine, Kragujevac , Serbia
| | - Dalibor Jovanovic
- University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Pathology, Kragujevac , Serbia
| | - Zeljko Todorovic
- University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Internal medicine, Kragujevac , Serbia
| | - Marija Zivkovic
- Center of Oncology, Clinical Center “Kragujevac”, Kragujevac , Serbia
| | - Aleksandar Dagovic
- University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Clinical oncology, Kragujevac , Serbia
| | - Slobodanka Mitrović
- University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Pathology, Kragujevac , Serbia
| | - Marina Petrović
- University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Internal medicine, Kragujevac , Serbia
| | - Jelena Nešić
- University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Internal medicine, Kragujevac , Serbia
| |
Collapse
|
15
|
El-Tani Z, Duc C, Gluecker T, Cottier O. Intramammary metastatic melanoma of unknown primary origin in a 58-year old patient: a case report. J Med Case Rep 2016; 10:363. [PMID: 27998306 PMCID: PMC5175386 DOI: 10.1186/s13256-016-1117-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2016] [Accepted: 10/24/2016] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND Malignant melanoma metastasis to the breast is a rare disease. CASE PRESENTATION We present the case of a 58-year-old postmenopausal Caucasian woman with metastatic malignant melanoma of unknown origin of the right breast. She presented with a palpable lump in the inferior quadrant of her right breast. The investigations concluded it was breast metastasis from a malignant melanoma of unknown origin. The treatment consisted of mastectomy and axillary lymph node dissection. Two lymph nodes were positive for tumor cells and one showed extracapsular extension. Our patient did not receive immediate adjuvant therapy. Six weeks after the surgery, our patient presented a relapse in the right axilla (a 6 × 4 cm mass) with positive internal mammary lymph nodes and a single brain metastasis. This relapse motivated an adjuvant treatment with partial regression of the disease. Currently, our patient presents multiple metastases with poor prognosis. CONCLUSIONS From this experience, we advocate an immediate aggressive handling of melanoma metastasis to the breast.
Collapse
Affiliation(s)
- Zeina El-Tani
- Service de Gynécologie-Obstétrique, HRC (Hôpital Riviera-Chablais), Aigle, Switzerland
| | | | - Thomas Gluecker
- Service de Radiodiagnostic et de Radiologie, HRC Suisse, Aigle, Switzerland
| | - Olivier Cottier
- Service de Gynécologie-Obstétrique, HRC (Hôpital Riviera-Chablais), Aigle, Switzerland
| |
Collapse
|
16
|
Qu FL, Bernard L, Benabu JC, Dubost V, Gharbi M, Mathelin C. [Mammary metastasis from lung neuroendocrine tumor: Place of loco-regional treatment]. ACTA ACUST UNITED AC 2016; 44:452-4. [PMID: 27426692 DOI: 10.1016/j.gyobfe.2016.06.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2016] [Accepted: 05/31/2016] [Indexed: 02/02/2023]
Affiliation(s)
- F L Qu
- Unité de sénologie, hôpitaux universitaires de Strasbourg, hôpital Hautepierre, CHRU de Strasbourg, avenue Molière, 67200 Strasbourg cedex, France; Unité de sénologie, hôpital Ruijin, avenue 2(e) Ruijin, 20025 Shanghai, Chine
| | - L Bernard
- Unité de sénologie, hôpitaux universitaires de Strasbourg, hôpital Hautepierre, CHRU de Strasbourg, avenue Molière, 67200 Strasbourg cedex, France.
| | - J-C Benabu
- Unité de sénologie, hôpitaux universitaires de Strasbourg, hôpital Hautepierre, CHRU de Strasbourg, avenue Molière, 67200 Strasbourg cedex, France
| | - V Dubost
- Unité de sénologie, hôpitaux universitaires de Strasbourg, hôpital Hautepierre, CHRU de Strasbourg, avenue Molière, 67200 Strasbourg cedex, France
| | - M Gharbi
- Unité de sénologie, hôpitaux universitaires de Strasbourg, hôpital Hautepierre, CHRU de Strasbourg, avenue Molière, 67200 Strasbourg cedex, France
| | - C Mathelin
- Unité de sénologie, hôpitaux universitaires de Strasbourg, hôpital Hautepierre, CHRU de Strasbourg, avenue Molière, 67200 Strasbourg cedex, France; Institut de génétique et de biologie moléculaire et cellulaire, biologie du cancer (IGBMC), 1, rue Laurent-Fries, 67400 Illkirch-Graffenstaden, France
| |
Collapse
|
17
|
Chen Y, Wei H, Li J, Liu X, Fu P. Breast metastasis from signet ring cell carcinoma of the urinary bladder: A case report. Mol Clin Oncol 2016; 5:111-112. [PMID: 27330778 DOI: 10.3892/mco.2016.884] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2015] [Accepted: 01/13/2016] [Indexed: 11/05/2022] Open
Abstract
Carcinoma of the bladder metastatic to the breast is only sporadically reported in the literature. To the best of our knowledge, the present report is the first described case of signet ring cell carcinoma of the urinary bladder metastasizing to the breast. The patient was a 43-year-old woman who underwent transurethral partial cystectomy for signet ring cell carcinoma of the urinary bladder and adjuvant chemotherapy with cisplatin and gemcitabine. At 7 months postcystectomy, the patient presented with a solitary nodule in the right breast. Following transdermic core needle puncture biopsy of the lesion and histological examination, the tumor was found to be composed of signet ring cells, which were similar to the cells in the original cystectomy specimen. The patient underwent mastectomy without further chemotherapy and has remained free from metastasis to other organs during 1 year follow-up.
Collapse
Affiliation(s)
- Yaomin Chen
- Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
| | - Haiyan Wei
- Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
| | - Jun Li
- Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
| | - Xiaojiao Liu
- Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
| | - Peifen Fu
- Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
| |
Collapse
|
18
|
Abstract
Duodenal adenocarcinoma, a very rare malignant gastrointestinal tumor, mainly metastasizes via the lymphatic system. Metastases from duodenal adenocarcinomas to the breast are very uncommon. A 31-year-old woman presented at our department with a left breast tumor. She had a past medical history of duodenal adenocarcinoma. Physical examination on admission confirmed a 2.5-cm-diameter tumor in the outer lower quadrant of the left breast. Computed tomography (CT) examination showed a soft lesion with tissue-like density and enlarged axillary lymph nodes. Local excision was performed to remove the breast lesion. The findings of cytologic, histologic, and immunohistochemistry examination indicated a breast metastasis from the previous duodenal adenocarcinoma. The patient was treated with palliative chemotherapy. Metastases from duodenal adenocarcinoma to the breast are rare. The diagnosis depends on medical history, imaging, and pathologic examination including immunohistochemistry. An accurate diagnosis is important to avoid unnecessary surgery.
Collapse
Affiliation(s)
- Haibo Yu
- From the Department of Surgery (HY, HS); and Department of Pathology (YJ), The Dingli Clinical Institute of Wenzhou Medical University (Wenzhou Central Hospital), Da Jian Lane 32, Wenzhou, Zhejiang, Republic of China
| | | | | |
Collapse
|
19
|
Koch A, Stoll F, Duclos B, Chenard MP, Mathelin C. Intramammary metastasis of renal cell carcinoma: A diagnostic trap. ACTA ACUST UNITED AC 2016; 44:128-9. [PMID: 26852064 DOI: 10.1016/j.gyobfe.2015.12.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2015] [Accepted: 12/14/2015] [Indexed: 11/26/2022]
Affiliation(s)
- A Koch
- Unité de sénologie, pôle de gynécologie-obstétrique, hôpital Hautepierre, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg cedex, France.
| | - F Stoll
- Unité de sénologie, pôle de gynécologie-obstétrique, hôpital Hautepierre, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg cedex, France
| | - B Duclos
- Hôpital Hautepierre, pôle d'hématologie et d'oncologie, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg cedex, France
| | - M-P Chenard
- Hôpital Hautepierre, pôle d'anatomopathologie, hôpitaux universitaire de Strasbourg, 1, avenue Molière, 67200 Strasbourg cedex, France
| | - C Mathelin
- Unité de sénologie, pôle de gynécologie-obstétrique, hôpital Hautepierre, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg cedex, France
| |
Collapse
|
20
|
Framarino-dei-Malatesta M, Sammartino P, Derme M, Iannini I, Masselli G, Pecorella I. Breast cancer or metastasis? An unusual case of metastatic malignant pleural mesothelioma to the breast. World J Surg Oncol 2015; 13:79. [PMID: 25849448 PMCID: PMC4349678 DOI: 10.1186/s12957-015-0491-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2014] [Accepted: 02/01/2015] [Indexed: 11/23/2022] Open
Abstract
Background Metastases to the breast from extramammary malignancies are very rare, and ruling out the diagnosis of primary breast tumor is important in order to decide on clinical management and predict prognosis. Case presentation Clinical examination revealed in a 49-year-old hairdresser a 3-cm hard lump adherent to the underlying layers in the right breast. Trucut biopsy was performed. Histology showed a solid proliferation of medium-sized neoplastic polygonal cells. Immunohistochemical analysis showed tumor cells diffusely positive for cytokeratin 8/18 and calretinin and focally positive for cytokeratin 5/6 and Wilms’ tumor 1, e-cadherin, and human bone marrow endothelial-1. Estrogen receptors and progesterone receptors were negative. The final diagnosis was metastatic epithelioid malignant pleural mesothelioma. Conclusions Immunohistochemistry is an important tool for a conclusive diagnosis of malignant pleural mesothelioma. Owing to the degree of histological and immunohistochemical overlap, a high level of clinical suspicion is essential in order to avoid unnecessary mutilating surgery.
Collapse
|